e-learning
resources
Barcelona 2010
Sunday, 19.09.2010
Different patterns of interstitial lung disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Potential causes of acute deterioration in patients with interstitial lung disease
J. Su, H. Dai, Q. Ye, S. Zhang, C. Ban, M. Zhu (Beijing, China)
Source:
Annual Congress 2010 - Different patterns of interstitial lung disease
Session:
Different patterns of interstitial lung disease
Session type:
Thematic Poster Session
Number:
792
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Su, H. Dai, Q. Ye, S. Zhang, C. Ban, M. Zhu (Beijing, China). Potential causes of acute deterioration in patients with interstitial lung disease. Eur Respir J 2010; 36: Suppl. 54, 792
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Ambulatory management of primary spontaneous pneumothorax
Related content which might interest you:
Acute exacerbation of interstitial lung diseases as a cause of respiratory failure. Our 3-years experience
Source: Annual Congress 2010 - Clinical issues in diffuse parenchymal lung disease
Year: 2010
A large cohort study of clinical outcomes and prognostic predictors in patients with acute exacerbation of idiopathic pulmonary fibrosis
Source: International Congress 2014 – IPF and surroundings
Year: 2014
Effects of pulmonary rehabilitation in patients with severe COPD in comparison to patients with severe interstitial lung disease
Source: Annual Congress 2013 –The best posters in pulmonary rehabilitation
Year: 2013
Diffuse parenchymal lung diseases presenting with acute hypoxemic failure
Source: International Congress 2017 – Pulmonary emergencies year in review
Year: 2017
Addition of respiratory hospitalizations 24weeks prior to the ILD-GAP model to predict mortality in chronic interstitial lung disease
Source: International Congress 2016 – Clinical aspects of ILD
Year: 2016
Using the ILD-GAP model to predict mortality in chronic interstitial lung disease
Source: International Congress 2015 – IIPs: orphan
Year: 2015
Severe fatigue is highly prevalent in patients with interstitial lung disease
Source: Virtual Congress 2020 – A fresh look at the spectrum of symptoms in respiratory disease
Year: 2020
Walking assessments as the predictor of acute respiratory failure in the interstitial lung disease patients.
Source: Virtual Congress 2020 – The multiple facets of pulmonary rehabilitation and chronic respiratory care
Year: 2020
Analysis of parameters of lung function in patients with severe chronic obstructive pulmonary disease
Source: Eur Respir J 2001; 18: Suppl. 33, 214s
Year: 2001
Patients profile and pulmonary rehabilitation in interstitial lung disease
Source: International Congress 2018 – Aspects of pulmonary rehabilitation and chronic care
Year: 2018
Acute exacerbations of interstitial lung disease
Source: Eur Respir Monogr 2016; 74: 117-131
Year: 2016
Autopsy-proven pulmonary determinants in patients with acute respiratory failure
Source: Annual Congress 2010 - Intensive care unit outcome
Year: 2010
Rituximab treatment of a case of anti-syntetase syndrome with severe interstitial lung disease and acute respiratory failure
Source: Annual Congress 2010 - Clinical issues in diffuse parenchymal lung disease
Year: 2010
Variability in expression of aquoporine 1 in chronic obstructive pulmonary disease and interstitial lung disease patients
Source: Annual Congress 2009 - What is new in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease?
Year: 2009
Predictors of progression in systemic sclerosis patients with interstitial lung disease
Source: Eur Respir J, 55 (5) 1902026; 10.1183/13993003.02026-2019
Year: 2020
Clinical features and outcome of patients with acute exacerbation of interstitial pneumonia associated with collagen vascular disease
Source: Annual Congress 2010 - Clinical aspects in pulmonary fibrosis
Year: 2010
Impact of COVID-19 on patients with chronic lung disease
Source: Virtual Congress 2021 – COVID - 19 epidemiology
Year: 2021
Differences of acute exacerbations in idiopathic pulmonary fibrosis compared to other fibrotic lung diseases
Source: International Congress 2019 – The world of idiopathic pulmonary fibrosis
Year: 2019
Acute exacerbation of idiopathic pulmonary fibrosis as the initial presentation of the disease
Source: Eur Respir Rev 2009; 18: 129-132
Year: 2009
Clinical course and outcomes of acute exacerbation of fibrosing interstitial lung disease
Source: Virtual Congress 2021 – Prognostic markers of disease progression in non-idiopathic pulmonary fibrosis interstitial lung diseases
Year: 2021
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept